This topic contains a solution. Click here to go to the answer

Author Question: Which of the following adverse changes in vital signs may result from administration of ... (Read 11 times)

chads108

  • Hero Member
  • *****
  • Posts: 507
Which of the following adverse changes in vital signs may result from administration of sargra-mostim (Leukine)?
 
  a. Bradycardia
  b. Hypertension
  c. Hypothermia
  d. Fever

Question 2

Which of the following statements most accurately describes mycophenolate (CellCept)?
 
  a. It is an antineoplastic drug with relatively few adverse effects.
  b. It is an antimicrobial drug that also has antineoplastic properties.
  c. It is an immunosuppressant used to prevent organ rejection.
  d. It is an interleukin that has not obtained Food and Drug Administration (FDA) approval to date.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

softEldritch

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

ANS: D
Peripheral edema, weight gain, dyspnea, fever, and leukocytosis occasionally occur with admin-istration of sargramostim (Leukine).

Answer to Question 2

ANS: C
Mycophenolate is an immunosuppressant used to prevent rejection in patients with an allogenic renal transplant.




chads108

  • Member
  • Posts: 507
Reply 2 on: Jul 23, 2018
:D TYSM


lindahyatt42

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

For a complete list of videos, visit our video library